Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9153748 | American Heart Journal | 2005 | 16 Pages |
Abstract
The results of OAT should have broad clinical impact by defining an evidence-based approach to the asymptomatic, high-risk, post-MI patient with an occluded IRA. If the efficacy and cost-effectiveness of percutaneous coronary intervention are established, then a policy of routinely seeking and opening persistently occluded IRAs could be advocated. If not, this strategy should be avoided in this large subgroup of post-MI patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
The Occluded Artery Trial (OAT) Research Group The Occluded Artery Trial (OAT) Research Group, Judith S. MD, Gervasio A. MD, Genell L. PhD, Christopher E. MD, Vladimir MD, Daniel B. MD, Harmony R. MD, Harvey D. MD,